Literature DB >> 20711782

Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus.

Mehmet Sayarlioglu1, Nergis Yuzbasioglu, Murat Inanc, Sevil Kamali, Ayse Cefle, Ozcan Karaman, Ahmet Mesut Onat, Rustem Avan, Gozde Yildirm Cetin, Ahmet Gul, Lale Ocal, Orhan Aral.   

Abstract

The objective was to investigate the predictive factors for avascular necrosis (AVN) of bone in patients with systemic lupus erythematosus (SLE). The records of 868 patients with SLE from four centers were reviewed retrospectively. Forty-nine patients with AVN were identified. A total of 154 patients with SLE who did not have clinically apparent AVN during the follow-up were evaluated as a control group. The demographic, clinical, laboratory and management characteristics of these two groups of patients were recorded according to predefined protocol and compared. The prevalence of AVN was detected 6% in our SLE population. The highest dose corticosteroid administered within 4 months and total cumulative prednisolone dose were significantly higher in the SLE patients with AVN. The use of cytotoxic agent significantly higher proportion of patients with AVN. AVN tends to develop more frequently in male gender and younger patients. Oral ulcer, pleuritis, Raynaud's phenomenon, cutaneous vasculitis, lymphadenopathy, autoimmune thyroiditis, peripheral neuropathy and Sjögren's syndrome were higher incidence in SLE patients with AVN. The bilateral femoral heads were the commonest site of involvement of AVN in our patients with SLE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20711782     DOI: 10.1007/s00296-010-1597-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  19 in total

1.  Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?

Authors:  M Y Mok; V T Farewell; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

2.  Ischemic necrosis of bone in systemic lupus erythematosus.

Authors:  A R Klipper; M B Stevens; T M Zizic; D S Hungerford
Journal:  Medicine (Baltimore)       Date:  1976-05       Impact factor: 1.889

3.  Arthropathy associated with steroid therapy.

Authors:  E E Velayos; J D Leidholt; C J Smyth; R Priest
Journal:  Ann Intern Med       Date:  1966-04       Impact factor: 25.391

4.  Risk factors for osteonecrosis in systemic lupus erythematosus.

Authors:  M A Mont; C J Glueck; I H Pacheco; P Wang; D S Hungerford; M Petri
Journal:  J Rheumatol       Date:  1997-04       Impact factor: 4.666

5.  Risk factors for avascular bone necrosis in systemic lupus erythematosus.

Authors:  C C Mok; C S Lau; R W Wong
Journal:  Br J Rheumatol       Date:  1998-08

6.  Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities.

Authors:  K Nagasawa; Y Ishii; T Mayumi; Y Tada; A Ueda; Y Yamauchi; T Kusaba; Y Niho
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

7.  Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus.

Authors:  T M Zizic; C Marcoux; D S Hungerford; J V Dansereau; M B Stevens
Journal:  Am J Med       Date:  1985-11       Impact factor: 4.965

8.  Avascular necrosis in SLE. An apparent predilection for young patients.

Authors:  F E Smith; D E Sweet; C M Brunner; J S Davis
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

9.  Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE.

Authors:  J Dimant; E M Ginzler; H S Diamond; M Schlesinger; C T Marino; M Weiner; D Kaplan
Journal:  J Rheumatol       Date:  1978       Impact factor: 4.666

10.  Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging.

Authors:  Maria G Tektonidou; Katerina Malagari; Panayiotis G Vlachoyiannopoulos; Dimitris A Kelekis; Haralampos M Moutsopoulos
Journal:  Arthritis Rheum       Date:  2003-03
View more
  23 in total

1.  Osteonecrosis in SLE.

Authors:  M Abeles; A M Abeles; J Urman; N Rothfield
Journal:  Rheumatol Int       Date:  2011-02-22       Impact factor: 2.631

2.  Systemic lupus erythematosus patients with high disease activity are associated with accelerated incidence of osteonecrosis: a systematic review and meta-analysis.

Authors:  Kui Zhang; Yan Zheng; Junfeng Jia; Jin Ding; Zhenbiao Wu
Journal:  Clin Rheumatol       Date:  2017-09-25       Impact factor: 2.980

3.  The risk factors of avascular necrosis in patients with systemic lupus erythematosus: a meta-analysis.

Authors:  Kao-Kao Zhu; Wang-Dong Xu; Hai-Feng Pan; Min Zhang; Jing Ni; Fu-Yang Ge; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

4.  [Unclear hip pain in systemic sclerosis. Osteonecrosis].

Authors:  M Buslau; D Spitzenberger
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

5.  Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study.

Authors:  Young Bin Joo; Yoon-Kyoung Sung; Jee-Seon Shim; Jae-Hoon Kim; Eui-Kyung Lee; Hye-Soon Lee; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2014-10-10       Impact factor: 2.631

6.  Prevalence of clinical anxiety, clinical depression and associated risk factors in chinese young and middle-aged patients with osteonecrosis of the femoral head.

Authors:  Sheng-Bao Chen; Hai Hu; You-Shui Gao; Hai-Yan He; Dong-Xu Jin; Chang-Qing Zhang
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

7.  Risk factors of avascular necrosis in Takayasu arteritis: a cross sectional study.

Authors:  Neslihan Gokcen; Andac Komac; Fatma Tuncer; Gizem Kocak Buyuksutcu; Ozlem Ozdemir Isik; Ayten Yazici; Ayse Cefle
Journal:  Rheumatol Int       Date:  2021-06-06       Impact factor: 2.631

Review 8.  Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment.

Authors:  Jeremy T Hines; Woo Lam Jo; Quanjun Cui; Michael A Mont; Kyung Hoi Koo; Edward Y Cheng; Stuart B Goodman; Yong Chan Ha; Phillippe Hernigou; Lynne C Jones; Shin Yoon Kim; Takashi Sakai; Nobuhiko Sugano; Takuaki Yamamoto; Mel S Lee; Dewei Zhao; Wolf Drescher; Tae Young Kim; Young Kyun Lee; Byung Ho Yoon; Seung Hoon Baek; Wataru Ando; Hong Seok Kim; Jung Wee Park
Journal:  J Korean Med Sci       Date:  2021-06-21       Impact factor: 2.153

9.  Glucocorticoid-induced avascular bone necrosis: diagnosis and management.

Authors:  K L Chan; C C Mok
Journal:  Open Orthop J       Date:  2012-10-05

10.  Prevalence of avascular necrosis in idiopathic inflammatory myopathies: a single-centre experience.

Authors:  Khalil I Bourji; Christopher A Mecoli; Julie J Paik; Jemima Albayda; Eleni Tiniakou; William Kelly; Thomas E Lloyd; Andrew Mammen; Shivani Ahlawat; Lisa Christopher-Stine
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.